Mar 2026 $72 M Issued in a merger or acquisition $50 to $250 million 80
4C Medical Technologies, Inc.: Private sale, Mar 2026 × Investors in this round 80 investors had bought by the notice of Mar 31, 2026: 80 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $72 M of $166 M offered; $94 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $9,295,063
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harley Handegard · Executive Officer Katherine Kumar · Executive Officer Saravana Kumar · Executive Officer, Director Buzz Benson · Director Jeffrey Chambers · Director Jonathan Chen · Director Rhonda Robb · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Piper Sandler & Co. (CRD 665) · broker-dealer Piper Sandler & Co. (CRD 665) · Minneapolis, Minnesota Sold in all US states Remarks in the notice On fees: “Assumes all closings are completed.”On the amounts: “13(a) and (b) include the conversion of notes having an outstanding balance of $34,608,151. Excludes sales made to certain non-U.S. investors in reliance on Regulation S.”Signed by Harley Handegard, Chief Financial Officer. Newest notice filed Mar 31, 2026. Read the notice at the SEC .
equity, options SEC Mar 2025 $72 M Issued in a merger or acquisition $50 to $250 million 80
4C Medical Technologies, Inc.: Private sale, Mar 2025 × Investors in this round 80 investors had bought by the notice of Mar 19, 2025: 80 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $72 M of $166 M offered; $94 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $9,295,063
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Harley Handegard · Executive Officer Katherine Kumar · Executive Officer Saravana Kumar · Executive Officer, Director Buzz Benson · Director Jeffrey Chambers · Director Jonathan Chen · Director Rhonda Robb · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Piper Sandler & Co. (CRD 665) · broker-dealer Piper Sandler & Co. (CRD 665) · Minneapolis, Minnesota Sold in all US states Remarks in the notice On fees: “Assumes all closings are completed.”On the amounts: “13(a) and (b) include the conversion of notes having an outstanding balance of $34,608,151. Excludes sales made to certain non-U.S. investors in reliance on Regulation S.”Signed by Harley Handegard, Chief Financial Officer. Newest notice filed Mar 19, 2025. Read the notice at the SEC .
equity, options SEC Nov 2021 $35 M No. 4 $10 to $50 million 53
4C Medical Technologies, Inc.: Raise no. 4, Nov 2021 × Investors in this round 53 investors had bought by the notice of Nov 16, 2021: 53 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $35 M of $61 M offered; $25 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Katherine W. Kumar · Executive Officer Saravana Kumar · Executive Officer, Director Scott W. Youngstrom · Executive Officer Buzz W. Benson · Director Jeffrey W. Chambers · Director Jonathan W. Chen · Director Rhonda W. Robb · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Total Offering Amount and Total Amount Sold includes the exchange of promissory notes having an outstanding balance of $15,611,201.”Signed by Scott Youngstrom, Chief Financial Officer. Newest notice filed Nov 16, 2021. Read the notice at the SEC .
equity SEC Sep 2019 $8 M No. 3 $2 to $10 million 45
4C Medical Technologies, Inc.: Raise no. 3, Sep 2019 × Investors in this round 45 investors had bought by the notice of Oct 2, 2019: 45 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $20 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James E. Flaherty · Executive Officer Jeffrey W. Chambers · Executive Officer, Director, Promoter Katherine J. Kumar · Executive Officer Robert J. Thatcher · Executive Officer, Director Saravana J. Kumar · Executive Officer Buzz J. Benson · Director Jonathan J. Chen · Director William J. Hoffman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by James Flaherty, Secretary. Newest notice filed Oct 2, 2019. Read the notice at the SEC .
equity SEC Sep 2018 $17 M No. 2 $10 to $50 million 23
4C Medical Technologies, Inc.: Raise no. 2, Sep 2018 × Investors in this round 23 investors had bought by the notice of Sep 19, 2018: 23 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $17 M of $25 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice James E. Flaherty · Executive Officer Jeffrey W. Chambers · Executive Officer, Director, Promoter Katherine J. Kumar · Executive Officer Robert J. Thatcher · Executive Officer, Director Saravana J. Kumar · Executive Officer Jonathan J. Chen · Director William J. Hoffman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert J. Thatcher, Chief Executive Officer. Newest notice filed Sep 19, 2018. Read the notice at the SEC .
equity SEC Apr 2018 $3 M No. 1 $2 to $10 million 29
4C Medical Technologies, Inc.: Raise no. 1, Apr 2018 × Investors in this round 29 investors had bought by the notice of May 17, 2018: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $15 M offered; $12 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice James E. Flaherty · Executive Officer Jeffrey W. Chambers · Executive Officer, Director, Promoter Katherine J. Kumar · Executive Officer Robert J. Thatcher · Executive Officer, Director Saravana J. Kumar · Executive Officer William J. Hoffman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert J. Thatcher, Chief Executive Officer. Newest notice filed May 17, 2018. Read the notice at the SEC .
equity SEC